Abstract |
This study was aimed at evaluating the ability of a new functionally selective partial M1 agonist, AF150(S), to reverse cognitive impairments in rats. A memory deficits-induced animal model was used that involved AF64A (3 nmol/2 microliters/side) bilaterally injected ICV. AF150(S) was administered PO. The pharmacodynamic profile of the compound was established and its general toxicity was evaluated. Animals were tested on three behavioral tasks: step-through passive avoidance, Morris water maze reference memory paradigm, and radial arm maze working memory paradigm. The sign-free dose of AF150(S) was > 40 mg/kg whereas the LD50 was > 500 mg/kg. In comparison, the effective dose in reversing performance impairments on the various tasks was much lower (0.5-5 mg/kg). The data suggest that AF150(S) possesses potential cognitive enhancement abilities, probably due to a specific increase of cholinergic function.
|
Authors | R Brandeis, M Sapir, N Hafif, S Abraham, N Oz, E Stein, A Fisher |
Journal | Pharmacology, biochemistry, and behavior
(Pharmacol Biochem Behav)
Vol. 51
Issue 4
Pg. 667-74
(Aug 1995)
ISSN: 0091-3057 [Print] United States |
PMID | 7675841
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Aziridines
- Muscarinic Agonists
- Neuromuscular Blocking Agents
- ibuprofen dimethyl aminoethanol octyl
- ethylcholine aziridinium
- Choline
- Ibuprofen
|
Topics |
- Animals
- Anti-Inflammatory Agents, Non-Steroidal
(pharmacology)
- Avoidance Learning
(drug effects)
- Aziridines
(antagonists & inhibitors, pharmacology)
- Choline
(analogs & derivatives, antagonists & inhibitors, pharmacology)
- Cognition
(drug effects)
- Exploratory Behavior
(drug effects)
- Ibuprofen
(analogs & derivatives, pharmacology)
- Male
- Maze Learning
(drug effects)
- Memory
(drug effects)
- Muscarinic Agonists
(pharmacology)
- Neuromuscular Blocking Agents
(antagonists & inhibitors, pharmacology)
- Rats
- Rats, Sprague-Dawley
- Stimulation, Chemical
|